Aytu Biopharma, Inc

Ownership Transactions Reported by 13 Insiders

Symbol
AYTU on Nasdaq
Location
7900 E. Union Avenue, Suite 920, Denver, CO

Insiders trading volume in the past year

Aytu Biopharma, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Armistice Capital, Llc Director $5.02M Mar 20, 2021
Christopher Brooke Chief Operating Officer $2.18M Aug 11, 2023
Nantahala Capital Management, LLC 10%+ Owner $2.03M Jun 14, 2024
K. Oki Chief Financial Officer $355K Aug 11, 2023
Gary Cantrell Director $307K Dec 21, 2022
Joshua R. Disbrow Chief Executive Officer $113K +$19.5K +21% Feb 28, 2025
Greg Pyszczymuka Chief Commercial Officer $30.7K Mar 31, 2025
Ryan J. Selhorn Chief Financial Officer $20.8K Feb 5, 2025
Carl Dockery Director $19.5K Nov 6, 2024
Vivian H. Liu Director $18.4K Nov 6, 2024
Abhinav Jain Director $17.8K Nov 6, 2024
John Donofrio Jr. Director $7.03K Nov 6, 2024
Jarrett Disbrow Chief Business Officer Nov 6, 2024

Recent Insider Transactions by Companies or Individuals for Aytu Biopharma, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.